CD19 Mouse Monoclonal Antibody [Clone ID: HD37]

CAT#: AM39014PP-N

CD19 mouse monoclonal antibody, clone HD37, PerCP

Conjugation: Unconjugated FITC PE PerCP



Need it in bulk or conjugated?
Get a free quote

CNY 7,069.00


货期*
5周

规格
    • 100 Tests

Product images

Specifications

Product Data
Clone Name HD37
Applications FC
Recommend Dilution Anti-CD19 (clone HD37) can be applied in Flow Cytometry and in Immunohistochemistry using Frozen tissue sections.
Flow Cytometry: please see "Protocols" below.
Labelled reagent is effectively formulated for direct immunofluorescent staining.
Reactivity Human
Host Mouse
Clonality Monoclonal
Specificity Clone HD37 is specific for CD19, it recognizes a 95 kD transmembrane glycoprotein.

Testing by flow cytometry using a 'lyse-wash' method on whole blood from healthy donors showed the following values expressed in terms of % of the total lymphocyte count:

Product code: AM39014AC-N (anti-CD19 APC)
n: 9
Mean % positive: 9,16
S.D.: 1,95
% CV: 21,31
------------------------------------------
Product code: AM39014FC-N (anti-CD19 FITC)
n: 9
Mean % positive: 10,80
S.D.: 2,14
% CV: 19,79
------------------------------------------
Product code: AM39014RP-N (anti-CD19 PE)
n: 9
Mean % positive: 10,57
S.D.: 2,06
% CV: 19,49
------------------------------------------
Formulation 0.01 M sodium phosphate, 0.15 M NaCl, pH 7.3, 0.2% BSA, 0.09% sodium azide
Label: PerCP
State: Liquid purified Ig fraction
Label: Cat. No. Label EX-max (nm) / EM-max (nm):
AM39014AC-N APC 595, 633, 635, 647 / 660
AM39014FC-N FITC 488 / 519
AM39014RP-N PE 488, 532 / 578
AM39014PP-N PerCP 488, 532 / 678
AM39014PC5-N 488, 532 / 695
AM39014PU-N Pure . /
Concentration lot specific
Purification Affinity chromatography
Conjugation PerCP
Storage Condition Store the antibody undiluted at 2-8°C.
Fluorochrome labelled product is photosensitive and should be protected from light.
Gene Name CD19 molecule
Background Progenitor B cells mature in bone marrow and subsequently appear as mature CD19+ B cells in blood. After contact with foreign antigens and the appropriate T cell help, they may further differentiate to specific antibody-producing plasma cells.The function of the CD19 molecule is related to signal transfer and is involved in regulation of B cell proliferation. CD19 is considered to be a characteristic B cell marker and therefore commonly used in routine immunophenotyping. Detection of CD19 expressing cells is important in the diagnosis of leukemic precursor B cells (pre-B ALL), mature B cells (B ALL), and plasma cells. Distinction between subtypes of these (acute) leukemias can be performed using CD19 antibodies together with monoclonal antibodies to cytoplasmic or membrane Ig. A large number of B cell disorders can be effectively characterized by expression of CD19 and one or more additional antigens. One example is hairy cell leukemia (HCL), which shows specific expression of CD11c, CD19, CD20 and CD103. The combination CD103/CD19 is an important tool for diagnosis of HCL. Other valuable antibody combinations for distinction between different leukemias using CD19 antibodies are CD5/CD19 (e.g. Chronic Lymphatic Leukemia); CD10/CD19 (common ALL and pre-B ALL) and CD19/cyCD79a (Acute B cell leukemia).
CD19 may also be expressed on follicular dendritic cells.
Synonyms Leu-12, B-cell marker
Note 1. Conjugates with brighter fluorochromes, like PE and APC, will have a greater separation than those with dyes like FITC. When populations overlap, the percentage of positive cells using a selected marker can be affected by the choice of fluorescent label.
2. Use of monoclonal antibodies in patient treatment can interfere with antigen target recognition by this reagent. This should be taken into account when samples are analyzed from patients treated in this fashion.
3. Reagent data performance is based on EDTA-treated blood. Reagent performance can be affected by the use of other anticoagulants.

Protocol: Flow cytometry method for use with labelled (FITC, R-PE, APC, PerCP or PerCP-Cy5.5) monoclonal antibodies
1. Add 100 µl of EDTA-treated blood (i.e. approx. 10e6 leukocytes) to a 5 ml reagent tube. The content of one tube is sufficient to perform one test.
2. Add to each tube 10 µl of labelled monoclonal antibody. (Appropriate mouse Ig isotype control samples should always be included in any labelling study).
Vortex the tube to ensure thorough mixing of antibody and cells.
3. Incubate the tube for 15 minutes at room temperature in the dark.
4. Add 100 µl of a lyse reagent.
5. Incubate for 10 minutes at room temperature in the dark.
6. Add 2 ml of demineralized water and incubate for 10 minutes in the dark.
7. Centrifuge the labelled cell suspension for 2 minutes at 1000 x g.
8. Remove the supernatant and resuspend the cells in 200 µl of PBS.
9. Analyze by flow cytometry within four hours (alternatively, the cells may be fixed by 0.05% of formaline in buffered saline for analysis the next day. Some antigens are readily destroyed upon fixation and this should be taken into account when using this alternative).

Flow cytometry method for use with dual and triple combinations
1. Add 100 µl of EDTA-treated blood (i.e. approx. 10e6 leukocytes) to a 5 ml reagent tube. The content of one tube is sufficient to perform one test.
For combinations with anti-kappa and/or anti-lambda Ig see Application note below.
2. Add to each tube 20 µl of labelled monoclonal antibody combination.
(Appropriate mouse Ig isotype control samples should always be included in any labeling study).
3. Vortex the tube to ensure thorough mixing of antibody and cells.
4. Incubate the tube for 15 minutes at room temperature in the dark.
5. Add 100 µl of a lyse reagent and mix immediately.
6. Incubate for 10 minutes at room temperature in the dark.
7. Add 2 ml of demineralized water and incubate for 10 minutes in the dark.
8. Centrifuge the labelled cell suspension for 2 minutes at 1000 x g.
9. Remove the supernatant and resuspend the cells in 200 µl of PBS.
10. Analyze by flow cytometry within four hours (alternatively, the cells may be fixed by 0.05% of formaline in buffered saline for analysis the next day. Some antigens are readily destroyed upon fixation and this should be taken into account when using this alternative).
Application note for anti-kappa and/or anti-lambda Ig combinations
Add 2 ml of PBS containing 0.001% (v/v) Heparin (prewarmed to 37°C) to the cell suspension
Vortex, centrifuge (2 min at 300x g) and discard the supernatant.
Repeat this step twice.
Resuspend the pelleted blood cells in 100 µl PBS, pH 7.2, containing 0.001% (v/v) Heparin.

Flow cytometry method for use with purified monoclonal antibodies
1. Add 100 µl of EDTA-treated blood (i.e. approx. 10e6 leukocytes) to a 5 ml reagent tube. The content of one tube is sufficient to perform one test.
2. Add to each tube 10 µl of purified monoclonal antibody. (Appropriate mouse Ig isotype control samples should always be included in any labelling study).
Vortex the tube to ensure thorough mixing of antibody and cells.
3. Incubate the tube for 15 minutes at room temperature in the dark.
4. Wash the labelled cells by adding 2 ml of PBS containing 0.001% (v/v) Heparin, vortexing and centrifuging (2 min 1000 x g) and discard the supernatant.
5. Add 50 µl of appropriate dilution of F(ab)2 Rabbit Anti Mouse IgG fluorescent conjugate (e.g.FITC or R-PE) in PBS containing 0.001% (v/v) Heparin to the tube. It is recommended that the tube is protected from light.
6. Mix by vortexing and incubate for 15 minutes at room temperature in the dark.
7. Add 100 µl of a lyse reagent and mix immediately.
8. Incubate for 10 minutes at room temperature in the dark.
9. Add 2 ml of demineralized water and incubate for 10 minutes in the dark.
10. Centrifuge the labelled cell suspension for 2 minutes at 1000 x g.
11. Remove the supernatant and resuspend the cells in 200 µl of PBS.
12. Analyze by flow cytometry within four hours (alternatively, the cells may be fixed by 0.05% of formaline in buffered saline for analysis the next day. Some antigens are readily destroyed upon fixation and this should be taken into account when using this alternative).
Reference Data
Protein Families Druggable Genome, Transmembrane
Protein Pathways B cell receptor signaling pathway, Hematopoietic cell lineage, Primary immunodeficiency
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...